Hydromer, Inc. Announces Preliminary Financial Results for Q2 2025

Hydromer, Inc. (OTC: HYDI), a pioneer in coating technologies for medical devices, has disclosed its preliminary, unaudited financial outcomes for the quarter ending June 30, 2025. The company witnessed a 14% surge in revenue, reaching $0.94 million, up from $0.82 million in the corresponding quarter of the previous year. However, a net loss of $38,000 was reported, attributed to legal and professional fees alongside costs related to facility and equipment enhancements.

Michael E. Torti, CEO of Hydromer, emphasized the quarter's results as a testament to the company's robust customer relationships and the indispensable nature of its coating technologies in the medical device industry. Despite the incurred expenses impacting profitability, Torti views these as essential investments aimed at fostering innovation, expanding market reach, and enhancing financial performance in the forthcoming periods. The company's strategy is firmly anchored on advancing its product pipeline, cultivating new partnerships, and maintaining operational discipline.

Hydromer's commitment to innovation and scalability is unwavering, with a continued focus on operational efficiency, strengthening customer collaborations, and the development of next-generation technologies. The company's adherence to international standards, including ISO 9001:2015 and Good Manufacturing Practice (GMP), underscores its dedication to quality and excellence in serving global markets.

For more information on Hydromer's technologies and services, visit https://www.hydromer.com.

This announcement is significant as it sheds light on Hydromer's financial health and strategic direction, offering insights into the medical device coating industry's dynamics. The reported revenue growth amidst challenges reflects the sector's resilience and the critical role of innovative coating solutions in advancing medical technology. Stakeholders, including investors and industry partners, may find these developments indicative of Hydromer's potential for sustained growth and its capacity to navigate the complexities of the global market.